Hypera strikes 'transformational' Takeda deal

5 March 2020 - Deborah Wilkes

Premium

Brazil’s Hypera Pharma is strengthening its presence in Latin America by acquiring a portfolio of OTC and pharmaceutical products – including the Neosaldina brand – from Japan’s Takeda for USD825 million. The deal comes soon after Hypera announced the purchase of the Buscopan and Buscofem brands in Brazil.

Click tags below for more information on topics:

Hypera Pharma Takeda

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: